519 related articles for article (PubMed ID: 33036570)
21. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
[TBL] [Abstract][Full Text] [Related]
22. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review.
Juan J; Gil MM; Rong Z; Zhang Y; Yang H; Poon LC
Ultrasound Obstet Gynecol; 2020 Jul; 56(1):15-27. PubMed ID: 32430957
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and outcomes of adult COVID-19 patients co-infected with Mycoplasma pneumoniae.
Zha L; Shen J; Tefsen B; Wang Y; Lu W; Xu Q
J Infect; 2020 Sep; 81(3):e12-e15. PubMed ID: 32652163
[No Abstract] [Full Text] [Related]
24. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.
Izcovich A; Ragusa MA; Tortosa F; Lavena Marzio MA; Agnoletti C; Bengolea A; Ceirano A; Espinosa F; Saavedra E; Sanguine V; Tassara A; Cid C; Catalano HN; Agarwal A; Foroutan F; Rada G
PLoS One; 2020; 15(11):e0241955. PubMed ID: 33201896
[TBL] [Abstract][Full Text] [Related]
25. The twin epidemics: Prevalence of TB/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis.
Tesfaye B; Alebel A; Gebrie A; Zegeye A; Tesema C; Kassie B
PLoS One; 2018; 13(10):e0203986. PubMed ID: 30281631
[TBL] [Abstract][Full Text] [Related]
26. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
27. Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes.
Wee LE; Ko KKK; Ho WQ; Kwek GTC; Tan TT; Wijaya L
J Clin Virol; 2020 Jul; 128():104436. PubMed ID: 32447256
[TBL] [Abstract][Full Text] [Related]
28. Coinfection With HIV and SARS-CoV-2 in Wuhan, China: A 12-Person Case Series.
Hu Y; Ma J; Huang H; Vermund SH
J Acquir Immune Defic Syndr; 2020 Sep; 85(1):1-5. PubMed ID: 32568771
[TBL] [Abstract][Full Text] [Related]
29. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.
Sarkar S; Khanna P; Singh AK
J Med Virol; 2021 Apr; 93(4):2385-2395. PubMed ID: 33331656
[TBL] [Abstract][Full Text] [Related]
30. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
Buitrago-Garcia D; Egli-Gany D; Counotte MJ; Hossmann S; Imeri H; Ipekci AM; Salanti G; Low N
PLoS Med; 2020 Sep; 17(9):e1003346. PubMed ID: 32960881
[TBL] [Abstract][Full Text] [Related]
31. Comorbidity in context: Part 2. Ethicolegal considerations around HIV and tuberculosis during the COVID-19 pandemic in South Africa.
Rossouw TM; Nienaber AG; Boswell MT; Moodley K
S Afr Med J; 2020 Jun; 110(7):625-628. PubMed ID: 32880336
[TBL] [Abstract][Full Text] [Related]
32. HIV and Human Coronavirus Coinfections: A Historical Perspective.
Makoti P; Fielding BC
Viruses; 2020 Aug; 12(9):. PubMed ID: 32858801
[TBL] [Abstract][Full Text] [Related]
33. Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerations.
Wang Q; Cao Y; Liu X; Fu Y; Zhang J; Zhang Y; Zhang L; Wei X; Yang L
PLoS Negl Trop Dis; 2024 May; 18(5):e0012136. PubMed ID: 38739637
[TBL] [Abstract][Full Text] [Related]
34. Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury L; Lim B; Baskaran V; Lim WS
J Infect; 2020 Aug; 81(2):266-275. PubMed ID: 32473235
[TBL] [Abstract][Full Text] [Related]
35. An association between exposure to Middle East Respiratory Syndrome (MERS) and mortality rate of Coronavirus Disease 2019 (COVID-19).
Naeem U; Naeem A; Naeem MA; Naeem K; Mujtaba B; Mujtaba A; Khurshid A
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9172-9181. PubMed ID: 32965011
[TBL] [Abstract][Full Text] [Related]
36. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
37. COVID-19, SARS and MERS: are they closely related?
Petrosillo N; Viceconte G; Ergonul O; Ippolito G; Petersen E
Clin Microbiol Infect; 2020 Jun; 26(6):729-734. PubMed ID: 32234451
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.
Sun P; Qie S; Liu Z; Ren J; Li K; Xi J
J Med Virol; 2020 Jun; 92(6):612-617. PubMed ID: 32108351
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
40. Real estimates of mortality following COVID-19 infection.
Baud D; Qi X; Nielsen-Saines K; Musso D; Pomar L; Favre G
Lancet Infect Dis; 2020 Jul; 20(7):773. PubMed ID: 32171390
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
